Study Stopped
Contract was never finalized and UW GCA closed the study due to lack of funding and activity.
Aromatherapy and Pain
The Effect of Aromatherapy on the Incidence and Severity of Post Procedure Pain and Discomfort in Patients
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Effect of aromatherapy on pain and discomfort in patients who are receiving intramuscular stimulation therapy or trigger point injections for chronic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2025
Shorter than P25 for not_applicable chronic-pain
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 29, 2023
CompletedFirst Posted
Study publicly available on registry
June 20, 2023
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedJune 22, 2025
May 1, 2025
6 months
April 29, 2023
June 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Acute Pain
Examine the change in Acute Pain associated with two identical procedures involving muscle with either an aromatherapy intervention or control intervention. With each patient being their own control, patients will rate their acute pain immediately after the procedure on a 0-10 scale (0=No pain and 10=Pain as bad as you can imagine).
Immediately after the Procedure
Secondary Outcomes (1)
Change in Overall Experience
Immediately after the Procedure
Study Arms (2)
Aromatherapy before treatment
ACTIVE COMPARATORSubject receives aromatherapy before IMS treatment or trigger point injection
Placebo before treatment
PLACEBO COMPARATORSubject receives placebo before IMS treatment or trigger point injection
Interventions
5 deep breaths from packet prior to treatment
5 deep breaths from packet prior to treatment
Eligibility Criteria
You may qualify if:
- Have received at least one (1) prior IMS or trigger point injection treatment with researcher
- years of age or older
- English language speaker
- has completed Pain Tracker (clinic standard of care) questionnaire prior to study visit
- any analgesic medication taken must be consistent for both sessions
You may not qualify if:
- Non-English language speaker
- Age \<18
- Allergy to essential oils
- Asthmatic
- Patient unable to self-administer aromatherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heather Tick, MD
University of Washington
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor: School of Medicine
Study Record Dates
First Submitted
April 29, 2023
First Posted
June 20, 2023
Study Start
January 1, 2025
Primary Completion
July 1, 2025
Study Completion
July 1, 2025
Last Updated
June 22, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share